Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Oblato, Inc. — Rare Disease Pipeline | Kisho | Kisho
Oblato, Inc.
Other
2
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
glioma susceptibility 1
disufenton sodium
Orphan Designation
-
malignant glioma
Disufenton sodium
Orphan Designation
-
← Back to Companies
